Winton Group’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$14.2M Buy
+28,360
New +$13.6M 0.46% 44
2025
Q4
Sell
-29,800
Closed -$14.5M 1111
2025
Q3
$14.5M Buy
29,800
+13,486
+83% +$6.28M 0.54% 28
2025
Q2
$6.61M Buy
+16,314
New +$6.82M 0.34% 44
2024
Q3
Sell
-600
Closed -$332K 767
2024
Q2
$332K Buy
+600
New +$344K 0.02% 476
2023
Q2
Sell
-351
Closed -$202K 1105
2023
Q1
$202K Buy
+351
New +$198K 0.01% 907
2022
Q1
Sell
-6,487
Closed -$4.33M 1144
2021
Q4
$4.33M Buy
6,487
+2,306
+55% +$1.44M 0.26% 64
2021
Q3
$2.39M Sell
4,181
-494
-11% -$271K 0.13% 129
2021
Q2
$2.36M Buy
4,675
+735
+19% +$347K 0.13% 130
2021
Q1
$1.8M Buy
3,940
+213
+6% +$102K 0.1% 185
2020
Q4
$1.74M Sell
3,727
-4,303
-54% -$2.02M 0.13% 157
2020
Q3
$3.54M Sell
8,030
-3,052
-28% -$1.26M 0.12% 255
2020
Q2
$4.01M Buy
+11,082
New +$3.71M 0.1% 310
2020
Q1
Sell
-772
Closed -$251K 1545
2019
Q4
$251K Sell
772
-11,823
-94% -$3.58M ﹤0.01% 1407
2019
Q3
$3.67M Sell
12,595
-15,267
-55% -$4.37M 0.04% 393
2019
Q2
$8.18M Sell
27,862
-10,798
-28% -$2.97M 0.16% 187
2019
Q1
$10.6M Sell
38,660
-7,390
-16% -$1.84M 0.21% 185
2018
Q4
$10.3M Buy
46,050
+7,384
+19% +$1.73M 0.22% 198
2018
Q3
$9.44M Buy
38,666
+10,312
+36% +$2.37M 0.2% 206
2018
Q2
$5.87M Sell
28,354
-27,552
-49% -$5.85M 0.15% 255
2018
Q1
$11.5M Sell
55,906
-11,052
-17% -$2.32M 0.33% 66
2017
Q4
$12.7M Sell
66,958
-34,350
-34% -$6.58M 0.37% 58
2017
Q3
$19.2M Buy
101,308
+7,272
+8% +$1.32M 0.61% 37
2017
Q2
$16.4M Buy
94,036
+92,305
+5,332% +$15.5M 0.48% 52
2017
Q1
$266K Sell
1,731
-305
-15% -$46.6K 0.01% 420
2016
Q4
$287K Sell
2,036
-124,135
-98% -$18.3M 0.01% 422
2016
Q3
$20.1M Buy
126,171
+45,784
+57% +$7.06M 0.34% 109
2016
Q2
$11.9M Buy
80,387
+14,977
+23% +$2.21M 0.2% 178
2016
Q1
$9.26M Sell
65,410
-34,101
-34% -$4.57M 0.1% 232
2015
Q4
$14.1M Sell
99,511
-40,430
-29% -$5.39M 0.13% 221
2015
Q3
$17.1M Buy
139,941
+97,047
+226% +$12.6M 0.14% 251
2015
Q2
$5.57M Sell
42,894
-59,610
-58% -$7.77M 0.05% 316
2015
Q1
$13.8M Sell
102,504
-69,582
-40% -$8.97M 0.11% 262
2014
Q4
$21.6M Sell
172,086
-305,420
-64% -$37.1M 0.27% 144
2014
Q3
$58.1M Sell
477,506
-202,078
-30% -$24.6M 0.42% 73
2014
Q2
$80.2M Buy
+679,584
New +$80M 0.55% 23

Other funds holding TMO

Winton Group's TMO Position: Q2 2026 in Review

Winton Group opened a new position in Thermo Fisher Scientific (TMO) in Q2 2026: 28,360 shares worth $14.2M. The stake represents 0.46% of the portfolio and ranks #44 among its holdings. This is a return to the name: Winton Group previously reported a position in TMO as recently as Q3 2025.

Winton Group first reported a position in TMO in Q2 2014 and has held it in 35 quarters since. The position peaked at $80.2M in Q2 2014. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Winton Group held 28,360 shares of Thermo Fisher Scientific worth $14.2M as of Q2 2026.
  • Thermo Fisher Scientific was a new Winton Group position in Q2 2026.
  • Thermo Fisher Scientific made up 0.46% of Winton Group's portfolio in Q2 2026, its #44 holding.
  • Winton Group first reported a position in Thermo Fisher Scientific in Q2 2014 and has held it in 35 quarters since.
  • Winton Group's Thermo Fisher Scientific position peaked at $80.2M in Q2 2014.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Winton Group's 13F filing for Q2 2026, filed 7 Aug 2026.